Research date: 28 October 2026 Target identification: Spineart SA, Switzerland Corporate identity: Swiss spinal implant and surgical technology manufacturer, established in 2005 and operating internationally through direct offices and commercial distribution.1, 2
Direct Defence Contracting & Procurement
Israeli Ministry of Defence and IDF contracts
No public evidence identified.
Israeli state security bodies
No public evidence identified.
Defence trade directories and procurement registries
No public evidence identified.
Defence cooperation announcements
No public evidence identified.
Corporate identity and business operations
Spineart SA identifies itself as a spinal surgery technology company founded in Geneva in 2005, supplying surgeons and hospitals internationally with spinal implants, surgical instruments and enabling technologies.1, 3
The company’s published international contact directory identifies offices and facilities in Switzerland, France, the United States, Germany, Spain, Italy and the United Kingdom.2
The published directory does not identify an Israeli corporate office, although the company’s stated worldwide commercial reach does not establish whether independent Israeli distributors or end-users exist.1, 2
Ownership and controlling interests
Gimv NV invested EUR 30 million in Spineart in September 2016, establishing an investment relationship that continued through subsequent financing announcements.4, 5
EGS Beteiligungen AG became an investor in June 2020 through a CHF 50 million growth-equity investment; the original announcement identified Gimv as Spineart’s largest shareholder at that date.5
EGS Beteiligungen identifies its investment in Spineart as a minority shareholding and records 2020 as the initial investment year.6
Gimv’s consolidated financial report for the period ending 30 September 2025 reports a 45.4% beneficial interest in Spineart SA, 13.3 percentage points above the preceding comparative figure.7
A regulated announcement dated 26 September 2025 confirms that Gimv and EGS Beteiligungen supported a further CHF 25 million capital increase for Spineart’s medical technology development and international expansion.8
The available disclosures do not establish the current individual shareholdings of Spineart’s founders or the complete beneficial ownership of the remaining equity.5, 7
Named-entity military-channel screening
- Spineart SA: Swiss operating company and principal audit target; searched for IDF, IMOD, military procurement, defence contracts and settlement activity. No public evidence identified.1, 2
- Gimv NV: Disclosed investor holding 45.4% beneficial interest as of September 2025; searched for Israeli defence investments, military contracting and military-linked corporate acts attributable to Spineart. No public evidence identified.7, 8
- EGS Beteiligungen AG: Minority investor since 2020; searched for Israeli defence investments, military procurement and settlement-related activity. No public evidence identified.5, 6
- Spineart USA Inc: Named United States group entity; searched for Israeli military contracting, defence exports and Israeli security end-users. No public evidence identified.2
- Spineart (UK) Ltd: Identified UK operating entity, registered under company number 08328402; searched for defence exports, government contracts and Israeli military procurement. No public evidence identified.9
- Spineart Deutschland GmbH: Named German group entity; searched for defence supply and Israeli military customers. No public evidence identified.2
- Spineart España SLU: Named Spanish group entity; searched for Israeli military procurement and defence exports. No public evidence identified.2
- Spineart Italia S.R.L.: Named Italian group entity; searched for Israeli defence contracting and military distribution. No public evidence identified.2
- Jérôme Levieux: Co-founder and board director; searched for Israeli defence-industry directorships, military donations, investment vehicles and settlement-linked organisations. No public evidence identified.1, 3
- Stéphane Mugnier-Jacob: Co-founder and board director; searched for Israeli military relationships, defence-industry positions and military-support organisations. No public evidence identified.1, 5
- Jérôme Trividic: Group CEO; searched for defence-industry directorships, IDF-related philanthropic activity and Israeli military partnerships. No public evidence identified.1, 8
- Gino Poggiali: Senior executive and registered person with significant control of Spineart (UK) Ltd; searched for Israeli defence relationships and military-channel activities. No public evidence identified.1, 10
- Alessia Erlingher: Chief Commercial Officer; searched for Israeli military customers, defence distribution and military-support activities. No public evidence identified.1
- Guillaume Amblard: Chief Product Officer; searched for defence product development and military technology partnerships. No public evidence identified.1
- Max Lok: Senior regulatory and quality executive; searched for Israeli military export-control and defence technology activities. No public evidence identified.1
- Yohan Stalder: Executive Vice President of Operations; searched for defence manufacturing and military logistics relationships. No public evidence identified.1
- Stephan Cori: Finance executive and registered UK subsidiary director; searched for Israeli defence investments and military-related corporate acts. No public evidence identified.1, 11
- Laurent Nodé-Langlois: Chief Technology Officer; searched for defence robotics, military AI and weapons-system development. No public evidence identified.1
- Kevin Klein: Gimv-linked board representative; searched for defence-sector board positions and Israeli military investments. No public evidence identified.1
- Bart Diels: Gimv Managing Partner and Spineart board representative; searched for military-industry investments and Israeli defence relationships. No public evidence identified.1, 8
- Gautier Lefebvre: Gimv healthcare investor and Spineart board representative; searched for Israeli military-linked investment activity. No public evidence identified.1, 8
- Christian Pfab: EGS Beteiligungen executive representative; searched for military-industry investment and Israeli defence relationships. No public evidence identified.1, 8
- Dominik Sauter: EGS Beteiligungen investment representative; searched for Israeli defence-sector connections and military-linked corporate activity. No public evidence identified.1, 8
- Jean-Philippe Favre: Minority shareholder representative on Spineart’s board; searched for military investments, defence-industry positions and Israeli military-support activity. No public evidence identified.1
Historical control of the UK subsidiary
UK Companies House identifies Gino Jacques Francois Poggiali as the active person with significant control of Spineart (UK) Ltd, notified on 1 August 2022; previously notified persons include Jérôme Trividic, Stéphane Mugnier, Jérôme Levieux and Jérôme Ventura, whose recorded control had ceased by the dates shown in the register.10
These UK register entries concern significant influence or control of the UK legal entity and do not establish equivalent direct equity percentages in Swiss parent Spineart SA.10
Dual-Use Products & Tactical Variants
Medical product portfolio
Spineart describes a portfolio of spinal implants and associated surgical technologies used for motion preservation, spinal fusion, minimally invasive surgery and other clinical procedures.1, 3
Its published corporate information identifies sterile packaging, implant traceability and surgical instrumentation as features of its medical-device offering.1
The disclosed intended applications concern civilian clinical treatment and surgery rather than military weaponry or tactical operations.1, 3
Robotic surgical technology
Spineart and eCential Robotics announced a long-term collaboration on 16 December 2022 covering surgical robotics, navigation technology, spinal surgery applications and commercialisation of an open robotic surgery platform.12
Spineart announced a EUR 10 million strategic investment in SpinEM Robotics on 30 April 2024, supporting development of robotic navigation and assistance technologies for spinal surgery.13
SpinEM Robotics describes its Odysseus platform as a robotic system for spinal surgery incorporating anatomical tracking technology.14
Spineart and eCential Robotics reported successful clinical deployment of their combined technologies at Providence St. Joseph Hospital in Orange, California, in July 2024.15
These documented systems are designed for spinal surgery and do not establish development or supply of weapons targeting, fire-control systems or military kill-chain automation.12, 13, 14, 15
Militarised variants
No public evidence identified.
Confirmed Israeli military sales
No public evidence identified.
End-user certificates and military export licences
No public evidence identified.
Act record - surgical robotics collaboration
- Acting entity: Spineart SA; recipient/counterparty: eCential Robotics; channel: commercial partnership disclosed through ecential-robotics.com; earliest observation: 16 December 2022; latest observation: the partnership remains described in Spineart’s corporate information available during the October 2026 research; status: publicly described as an ongoing partnership, with the precise contractual termination conditions undisclosed; audience: surgeons, hospitals and medical technology stakeholders.1, 12
- Acting entity: Spineart SA; recipient: SpinEM Robotics SAS; channel: investment and commercial-development announcement published through spineart.com; earliest observation: 30 April 2024; latest observation: continued identification of SpinEM Robotics as a partner in Spineart’s corporate information accessed in October 2026; status: publicly presented as an active commercial relationship, although subsequent equity transactions and precise current ownership are not established; audience: medical technology investors, surgeons and healthcare stakeholders.1, 13
- Acting entities: Spineart SA and eCential Robotics; clinical beneficiary: Providence St. Joseph Hospital, California; channel: corporate and partner announcements published through spineart.com and ecential-robotics.com; earliest and latest dated clinical observation: 25 July 2024; status: completed clinical event, with subsequent service-contract duration unspecified; audience: healthcare professionals, hospitals and medical technology stakeholders.15, 16
Heavy Machinery, Construction & Infrastructure
Equipment in occupied territories
No public evidence identified.
Construction or demolition equipment
No public evidence identified.
Military infrastructure development
No public evidence identified.
Settlement construction and infrastructure
No public evidence identified.
Geographic footprint
Spineart’s public corporate directory identifies a medical-device manufacturing location in Reignier-Esery, France, and headquarters in Plan-les-Ouates, Switzerland, together with several international commercial offices.2
The company’s disclosed manufacturing and operational locations do not establish the existence of a construction-equipment business or an operational facility in an Israeli settlement.2
Direct and indirect supply
No public evidence identified.
Settlement nexus
No public evidence identified.
Supply Chain Integration with Defence Primes
No public evidence identified.
Israel Aerospace Industries
No public evidence identified.
Rafael Advanced Defense Systems
No public evidence identified.
Israel Military Industries
No public evidence identified.
Defence component supply
No public evidence identified.
Joint development or licensed military production
No public evidence identified.
Identified commercial technology partners
Spineart SA maintains a documented medical technology partnership with eCential Robotics, focused on spinal implant integration with robotic surgical platforms.12
Spineart SA also entered a development relationship with SpinEM Robotics following a EUR 10 million investment announced on 30 April 2024.13
The named partners’ published activities concern surgical robotics and medical-device technologies.12, 14
Named partner screening
- eCential Robotics: Commercial collaborator; searched for IDF contracts, Israeli military procurement, defence-prime supply and military targeting technologies. No public evidence identified.12, 17
- SpinEM Robotics SAS: Commercial partner and investment recipient; searched for Israeli military customers, defence robotics, weapons systems and military procurement. No public evidence identified.13, 14
- Gimv NV: Substantial Spineart shareholder; searched for defence-prime investments and military-channel conduct attributable to its Spineart investment. No public evidence identified.7, 8
- EGS Beteiligungen AG: Spineart investor; searched for investments in Israeli defence manufacturers and operational integration with Israeli military supply chains. No public evidence identified.6, 8
Civilian technology supply-chain distinction
The December 2022 eCential Robotics agreement expressly concerns spine surgery applications and commercialisation of a surgical robotics platform.12
SpinEM Robotics identifies its technology as a spinal surgery system using anatomical tracking and robotic assistance.14
No public evidence identified of these documented technologies being developed as purpose-built kinetic military systems.
Logistical Sustainment & Base Services
IDF base-service contracts
No public evidence identified.
Military catering, transport, fuel or maintenance
No public evidence identified.
Military medical logistics contracts
No public evidence identified.
Military detention or security facilities
No public evidence identified.
Military shipping and freight
No public evidence identified.
Geographic specificity
No public evidence identified.
Ordinary commercial distribution
Spineart describes an international commercial presence involving surgeons and hospitals in more than 60 countries.1
Its corporate contact directory identifies direct offices in several European countries and the United States, without identifying a specific Israeli defence logistics customer.2
The existence of international medical distribution does not independently establish military logistics provision or supply to an Israeli security installation.1, 2
Munitions, Weapons Systems & Strategic Platforms
Small arms and infantry weapons
No public evidence identified.
Artillery and armoured vehicles
No public evidence identified.
Military drones and autonomous weapons
No public evidence identified.
Munitions and explosive precursor materials
No public evidence identified.
Missile defence systems
No public evidence identified.
Military aircraft and naval systems
No public evidence identified.
Weapons guidance and fire-control subsystems
No public evidence identified.
Military AI and targeting software
No public evidence identified.
Product-purpose verification
Spineart identifies spinal implants, clinical technologies and robotic surgical guidance as its product categories.1
SpinEM Robotics describes Odysseus as a spinal surgery system, and eCential Robotics describes the shared technology platform as a system for surgical imaging, navigation and robotics.12, 14
These documented intended purposes are clinical; no public evidence identified of a Spineart product designed to generate military targets, direct weapons or automate kinetic military effects.1, 12, 14
Export Licensing, Regulatory & Legal History
Israeli defence export licences
No public evidence identified.
Military end-user certificates
No public evidence identified.
Export-control enforcement
No public evidence identified.
Arms embargo or military sanctions proceedings
No public evidence identified.
Legal challenges concerning Israeli defence trade
No public evidence identified.
Civilian medical-device regulation
Spineart’s published corporate communications describe regulatory development of its BAGUERA C cervical disc and expansion of its medical product portfolio in the European and United States markets.8
The company’s publicly reported regulatory programme concerns medical-device authorisation rather than military export licensing.8
Corporate registration
Spineart (UK) Ltd is an active UK company, incorporated on 12 December 2012 under registration number 08328402.9
Companies House records its declared activities under hospital activities and specialist medical practice classifications.9
The company’s UK officer register identifies directors including Shane Aiken, Stephan Cori, Edouard Goetgheluck and Gino Poggiali.11
Constructive notice and cessation
The September 2025 capital increase confirms continuing investment activity by Gimv and EGS Beteiligungen after 19 July 2024 and November 2024; the stated purpose of that investment was medical technology development and international growth.8
No public evidence identified establishing that this financing continued, renewed or supported an Israeli military relationship.
No public evidence identified of a qualifying military supply relationship requiring assessment of termination, withdrawal or cessation.
Civil Society Scrutiny & Documented Investigations
UN settlement-business database
The Business & Human Rights Resource Centre reported that OHCHR’s September 2026 update to its settlement-business database identified 214 companies from 11 countries, expanding the scope of previously published assessments.18
No public evidence identified establishing inclusion of Spineart SA in the accessible records reviewed for this audit.
UN Special Rapporteur reporting
No public evidence identified establishing that Spineart SA was specifically named in connection with Israeli military supply in the UN Special Rapporteur materials located during this investigation.
Who Profits
No public evidence identified.
AFSC Investigate
No public evidence identified.
Amnesty International
No public evidence identified.
Human Rights Watch
No public evidence identified.
Al-Haq
No public evidence identified.
B’Tselem
No public evidence identified.
SOMO and BankTrack
No public evidence identified.
Don’t Buy Into Occupation
No public evidence identified.
Military-related boycott campaigns
No public evidence identified.
Shareholder resolutions or institutional divestment
No public evidence identified.
Corporate responses to military-supply allegations
No public evidence identified.
Public commercial communications
Spineart’s company information, available during the October 2026 research, continues to describe partnerships with eCential Robotics and SpinEM Robotics in connection with medical technology development.1
The earliest dated public announcement identified for its eCential collaboration is 16 December 2022, while the SpinEM investment announcement dates to 30 April 2024.12, 13
The latest verified observation of the partnership descriptions is the company information available during this research on 28 October 2026; publication history, removal intervals and exact individual audience reach could not be established from the accessible pages.1
No public evidence identified of a public statement by Spineart endorsing Israeli military operations, financing a named Israeli military-support organisation or announcing a military procurement relationship.
Corporate and investor communications
Gimv’s 2016 investment announcement described Spineart as a spinal medical-device developer and identified international expansion and product development as the intended use of the investment.4
Its September 2025 investment announcement similarly described Spineart’s activities as medical technology development, clinical innovation and international commercial expansion.8
Independent sector reporting
Becker’s Spine Review reported the April 2024 Spineart–SpinEM Robotics investment and development partnership as an initiative concerning robotic spinal surgery navigation.19
The reporting does not identify an Israeli defence customer or a weapons-development programme.19
Footnotes
-
Spineart, “Our company”, corporate overview and leadership information, accessed 28 October 2026. https://www.spineart.com/company/our-company/ ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7 ↩8 ↩9 ↩10 ↩11 ↩12 ↩13 ↩14 ↩15 ↩16 ↩17 ↩18 ↩19 ↩20 ↩21 ↩22 ↩23 ↩24 ↩25 ↩26 ↩27 ↩28 ↩29 ↩30 ↩31
-
Spineart, “Contact”, corporate offices, subsidiaries and manufacturing locations, accessed 28 October 2026. https://www.spineart.com/contact ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7 ↩8 ↩9 ↩10 ↩11 ↩12
-
Spineart, “Our story”, corporate history and development of spinal surgery products, accessed 28 October 2026. https://www.spineart.com/company/our-history/ ↩ ↩2 ↩3 ↩4
-
Gimv, “Gimv provides EUR 30 million of growth equity to fast-growing medical device company Spineart”, 20 September 2016 [pre-2020]. https://www.gimv.com/en/news/gimv-provides-eur-30-million-growth-equity-fast-growing-medical-device-company-spineart ↩ ↩2
-
Gimv, “Spineart welcomes EGS Beteiligungen AG which invests CHF 50 million of growth equity”, 4 June 2020. https://www.gimv.com/en/news/spineart-fast-growing-spinal-devices-company-welcomes-egs-beteiligungen-ag-which-invests-chf ↩ ↩2 ↩3 ↩4 ↩5
-
EGS Beteiligungen AG, “SpineArt”, portfolio investment profile identifying initial investment in 2020 and minority-shareholding status, accessed 28 October 2026. https://www.egs-beteiligungen.ch/en/portfolio/spineart ↩ ↩2 ↩3
-
Gimv NV, “Consolidated financial statements as of 30 September 2025”, half-year report 2025, printed page 25, beneficial ownership table. https://www.gimv.com/sites/default/files/media/2025-12/GIMV-HJV2025-EN%20(FINAAL).pdf ↩ ↩2 ↩3 ↩4
-
Gimv, regulated announcement, “Gimv and EGS Beteiligungen reinforce strategic support for Spineart with CHF 25 million capital increase to accelerate global growth”, 26 September 2025, published by WebDisclosure. https://www.webdisclosure.com/press-release/gimv-ebr-gimb-gimv-and-egs-beteiligungen-reinforce-strategic-support-for-spineart-with-chf-25-million-capital-increase-to-accelerate-global-growth-sfQnGiL2K5E ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7 ↩8 ↩9 ↩10 ↩11 ↩12 ↩13
-
UK Companies House, “SPINEART (UK) LTD”, company overview, registration number 08328402, accessed 28 October 2026. https://find-and-update.company-information.service.gov.uk/company/08328402 ↩ ↩2 ↩3
-
UK Companies House, “SPINEART (UK) LTD - Persons with significant control”, current and historical control notifications, accessed 28 October 2026. https://find-and-update.company-information.service.gov.uk/company/08328402/persons-with-significant-control ↩ ↩2 ↩3
-
UK Companies House, “SPINEART (UK) LTD - Officers”, current and historical company officers, accessed 28 October 2026. https://find-and-update.company-information.service.gov.uk/company/08328402/officers ↩ ↩2
-
eCential Robotics, “Spineart and eCential Robotics announce a partnership to co-develop spine surgery applications and co-market the eCential Robotics open robotic surgery platform”, 16 December 2022. https://www.ecential-robotics.com/en-gb/news/ecential-robotics-booste-la-technologie-de-sa-plateforme-avec-un-bras-robotis%C3%A9-chirurgical ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7 ↩8 ↩9 ↩10
-
Spineart, “SpinEM Robotics and Spineart forge strategic partnership with €10 million investment”, 30 April 2024. https://www.spineart.com/spinem-robotics-and-spineart-forge-strategic-partnership-with-e10-million-investment/ ↩ ↩2 ↩3 ↩4 ↩5 ↩6
-
SpinEM Robotics, corporate website and Odysseus surgical robotics description, accessed 28 October 2026. https://spinem-robotics.com/ ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7
-
eCential Robotics, “Successful completion of world’s first surgeries using eCential Open Robotic Platform for Spine”, 25 July 2024. https://www.ecential-robotics.com/en-gb/news/worlds-first-surgeries-using-ecential-open-robotic-and-navigation-platform-for-spine ↩ ↩2 ↩3
-
Spineart, “Providence St. Joseph Hospital performs world’s first spine surgery using eCential Robotics’ open spine robot, with Spineart compatible implants”, 25 July 2024. https://www.spineart.com/providence-st-joseph-hospital-performs-worlds-first-spine-surgery-using-ecential-robotics-open-spine-robot-with-spineart-compatible-implants-2/ ↩
-
eCential Robotics, “Our news and events”, announcements concerning commercial surgical robotics applications, accessed 28 October 2026. https://www.ecential-robotics.com/en-gb/news ↩
-
Business & Human Rights Resource Centre, “I/OPT: UN updates database of companies allegedly involved in illegal Israeli settlements, listing 214 companies from 11 countries”, 25 September 2026. https://www.business-humanrights.org/en/latest-news/iopt-un-updates-database-of-companies-involved-in-illegal-israeli-settlements-listing-214-companies-from-11-countries/ ↩
-
Becker’s Spine Review, “Spineart, SpinEM Robotics launch strategic partnership”, 30 April 2024. https://www.beckersspine.com/spinal-tech/spineart-spinem-robotics-launch-strategic-partnership/ ↩ ↩2